D. E. Shaw & Co., Inc. - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 112 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$12,000
-96.5%
13,274
-95.1%
0.00%
Q1 2022$339,000
+1203.8%
273,002
+1937.2%
0.00%
Q4 2021$26,000
-90.8%
13,401
-87.0%
0.00%
Q3 2021$282,000
-38.2%
102,998
-28.8%
0.00%
Q2 2021$456,000144,7540.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders